Crescendo Biologics Competitors and Similar CompaniesClear all
Crescendo Biologics's competitors and similar companies include Bruker Cellular Analysis, AbCellera Biologics, Celularity and Dualogics.
 Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. |  Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. |  AbCellera Biologics AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies. |  Celularity Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta. | ||
Founding Date | Founding Date 2007 | Founding Date 2011 | Founding Date 2012 | Founding Date 2016 | Founding Date 2015 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Babraham, GB HQ | Locations Emeryville, US HQ | Locations Vancouver, CA HQ | Locations Warren, US HQ Carlton, AU Madison, US | Locations HQ |
Employees | Employees 12 | Employees 1391% decrease | Employees 596 | Employees 1932% increase | Employees 4 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 833.9 m | Valuation ($) 37.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) £7.5m (FY, 2018) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) $75.1m (FY, 2025) | Revenue (est.) $26.6m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $24.8m (FY, 2022) | Cost of goods N/A | Cost of goods $20.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit £7.5m (FY, 2018) | Gross profit $53.8m (FY, 2022) | Gross profit N/A | Gross profit $6.5m (FY, 2025) | Gross profit N/A |
Net income | Net income (£1.8m) (FY, 2018) | Net income ($98m) (FY, 2022) | Net income ($146.4m) (FY, 2025) | Net income ($91.7m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 116.2m | Total funding raised $ 124.7m | Total funding raised $ 115m | Total funding raised $ 290m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bruker Cellular Analysis
HQ
Emeryville, US
Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.
View companyAbCellera Biologics
HQ
Vancouver, CA
Employees
596
AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies.
View companyCelularity
HQ
Warren, US
Employees
193↑ 2% increase
Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta.
View company